TNFRSF10B and cancer: With respect to anti-cancer candidate drugs that target MDSCs for elimination, for example, all-trans retinoic acid, certain tyrosine kinase inhibitors and TRAIL-R2 agonists were successfully used to eliminate MDSCs in cancer patients [91–96].